I recently took a position in RCE and plan to top up at later stages. There seems to be a little disenchantment on this thread about RCE matters. Anyone care to elaborate on that negativity - i.e. a lack of information about progress? I realise there is considerable risk involved with pharmaceutical development, but if the phase 1, 2 and 3 clinical trials prove positive, then the RCE share price should go gangbusters. A LOT of patience is required with this stock. Happy New Year to all RCE investors. I have a feeling 2018 will be rewarding.
I recently took a position in RCE and plan to top up at later...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $99.76M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.5¢ | 33.5¢ | $38.26K | 112.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10016 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 8605 | 1 |
View Market Depth
| Last trade - 15.56pm 18/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |